A Rare Complication: Development of an Aspergilloma after Endobronchial Coil Placement in a COPD Patient.
Aged
Antifungal Agents
/ therapeutic use
Bronchoscopy
Culture Techniques
Forced Expiratory Volume
Foreign Bodies
/ diagnostic imaging
Humans
Male
Pneumonectomy
Precipitin Tests
Pulmonary Aspergillosis
/ diagnosis
Pulmonary Emphysema
/ physiopathology
Severity of Illness Index
Surgical Instruments
Surgical Wound Infection
/ diagnosis
Tomography, X-Ray Computed
Voriconazole
/ therapeutic use
Aspergilloma
Bronchoscopic lung volume reduction
COPD
Endobronchial coils
Journal
Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356
Informations de publication
Date de publication:
Historique:
received:
05
08
2019
accepted:
14
09
2019
pubmed:
18
10
2019
medline:
22
4
2021
entrez:
18
10
2019
Statut:
ppublish
Résumé
Endobronchial coils are a relatively novel endoscopic lung volume reduction modality that aims to increase functional capacity in chronic obstructive pulmonary disease (COPD) patients. Two major trials have studied the safety and efficacy of this therapy, but long-term safety has not been studied. Adverse events reported are mainly periprocedural pneumothoraces and early bacterial infectious complications. We report the case of a patient with severe emphysema (Global Initiative for Chronic Obstructive Lung Disease stage IV COPD) who developed endobronchial coil-associated aspergillomas 3 years after coil placement.
Identifiants
pubmed: 31622972
pii: 000503363
doi: 10.1159/000503363
doi:
Substances chimiques
Antifungal Agents
0
Voriconazole
JFU09I87TR
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
423-425Informations de copyright
© 2019 S. Karger AG, Basel.